Population-based study of risk of venous thromboembolism associated with various oral contraceptives
- 1 January 1997
- journal article
- Published by Elsevier in The Lancet
- Vol. 349 (9045) , 83-88
- https://doi.org/10.1016/s0140-6736(96)07496-x
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- The increased risk of venous thromboembolism and the use of third generation progestagens: Role of bias in observational researchContraception, 1996
- Oral contraceptives and thrombotic diseases: Impact of new epidemiological studiesContraception, 1996
- Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control studyBMJ, 1996
- Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic diseaseThe Lancet, 1995
- Risk of idiopathic cardiovascular death and rionfatal venous thromboembolism in women using oral contraceptives with differing progestagen componentsThe Lancet, 1995
- Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagenThe Lancet, 1995
- Third generation oral contraceptive pillsBMJ, 1995
- Whipping up panic about the PillNature, 1995
- Risk Factors for Fatal Venous Thromboembolism in Young Women: A Case-Control StudyInternational Journal of Epidemiology, 1992
- Oral contraceptives and venous thromboembolism: findings in a large prospective study.BMJ, 1986